Veerhealth Care Ltd Q1 FY26 results press release summary

Results press release of 13 Aug 2025, summarised by AI from the filing.

Veerhealth Care reports Q1 FY26 total income of ₹5.14 cr, up 112.40% YoY, and guides FY26 revenues of ₹30-35 cr with PAT of 10%.

Key takeaways

1. FY26 guidance Expects total revenues of ₹30-35 cr with PAT of 10%.
2. USFDA clearance Received USFDA clearance, enabling exports of Drug (OTC) products to the USA and unlocking access to other international markets.
3. Export orders Secured first commercial order worth ₹0.48 crore for skin care and face care product manufacturing; received ₹0.74 crore export order for oral care products.
4. Production impact Production was impacted in the past 6-9 months due to facility expansion, renovation and upgrade for USFDA inspection.

Original filing on BSE

Veerhealth Care Ltd earnings call, investor presentation and press release summaries

• Q4 FY26: Results press release (2 Jun 2026)
• Q3 FY26: Results press release (16 Feb 2026)
• Q1 FY26: Results press release (13 Aug 2025)
• Other events: Strategy deck (27 Jun 2026), Strategy deck (25 Feb 2026)